{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:41:47Z","timestamp":1793788907936,"version":"4.6.1"},"reference-count":41,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Psoriasis is associated with an increased mortality risk, with cardiovascular disease being the leading excess cause (in a dose\u2013response manner with psoriasis severity). Statins have demonstrated a reduction in all\u2010cause mortality with no excess of adverse events among the general population. The underuse of interventions in cardiovascular prevention, such as statins, for patients with psoriasis may be the result of an insufficient evaluation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To provide the dermatologist with a tool for systematizing the treatment of dyslipidemia in psoriasis, which generally escapes the scope of dermatological practice, and to facilitate decision\u2010making about the referral and treatment of patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The Psoriasis Task Force of the European Academy of Dermatology and Venereology performed this two\u2010phase study to achieve a consensus and create recommendations on the use of statin therapy in patients with psoriasis. The first phase included a systematic review to identify a list of outline concepts and recommendations according to guidelines. The second phase consisted in a two\u2010round Delphi study to evaluate those recommendations not literally taken from guidelines.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A list of 47 concepts and recommendations to be followed by dermatologists involved in the treatment of patients with moderate\u2013severe psoriasis was created. It included six main concepts about cardiovascular risk and psoriasis, six items related with the role of low\u2010density lipoprotein cholesterol (LDL\u2010c) and the benefits of statin treatment in psoriasis patients, eight recommendations about how cardiovascular risk should be assessed, three on the role of non\u2010invasive cardiovascular imaging, three on LDL\u2010c thresholds, eight key points related to statin prescription, 10 on statin treatment follow\u2010up and three on patient referral to another specialist.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The application of this position statement (close final list of concepts and recommendations) will help dermatologists to manage dyslipidemia and help psoriasis patients to reduce their cardiovascular risk.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jdv.19191","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T10:29:06Z","timestamp":1685615346000},"page":"1697-1705","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Statins and psoriasis: Position statement by the Psoriasis Task Force of the European Academy of Dermatology and Venerology"],"prefix":"10.1111","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8060-4784","authenticated-orcid":false,"given":"A.","family":"Gonzalez\u2010Cantero","sequence":"first","affiliation":[{"name":"Department of Dermatology Hospital Universitario Ram\u00f3n y Cajal  Madrid Spain"},{"name":"Faculty of Medicine Universidad Francisco de Vitoria  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. H.","family":"Boehncke","sequence":"additional","affiliation":[{"name":"Division of Dermatology and Venereology Geneva University Hospitals  Geneva Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"De\u00a0Sutter","sequence":"additional","affiliation":[{"name":"Department of Cardiology AZ Maria Middelares  Ghent Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. L.","family":"Zamorano","sequence":"additional","affiliation":[{"name":"Departamento de Cardiolog\u00eda Hospital Universitario Ram\u00f3n y Cajal (IRYCIS)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lambert","sequence":"additional","affiliation":[{"name":"Department of Dermatology Ghent University Hospital  Ghent Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6083-0952","authenticated-orcid":false,"given":"L.","family":"Puig","sequence":"additional","affiliation":[{"name":"Department of Dermatology Hospital de la Santa Creu i Sant Pau  Barcelona Spain"},{"name":"Institut d'Investigaci\u00f3 Biom\u00e8dica Sant Pau (IIB SANT PAU)  Barcelona Spain"},{"name":"School of Medicine Universitat Aut\u00f2noma de Barcelona  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,6]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.14.1735"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwaa033"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-017-0533-0"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60367-5"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105057"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2019.90343"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.11.003"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.11.058"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz455"},{"issue":"1","key":"e_1_2_9_11_1","first-page":"e14","article-title":"Psoriasis and cardiovascular screening rates in the United States","volume":"12","author":"Alamdari HS","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14557"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.07.029"},{"key":"e_1_2_9_14_1","volume-title":"Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]","author":"Higgins JPT","year":"2011"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"issue":"2","key":"e_1_2_9_16_1","first-page":"349","article-title":"Expert opinion is necessary: Delphi panel methodology facilitates a scientific approach to consensus","volume":"34","author":"Hohmann E","year":"2018","journal-title":"Art Ther"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1108\/IJHCQA-02-2017-0042"},{"key":"e_1_2_9_18_1","volume-title":"The Delphi method, III: use of self ratings to improve group estimates","author":"Dalkey N","year":"1969"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.02.009"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab484"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.06.035"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.87a.19078"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2020.04.021"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2022.04.013"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000608"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15177"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-013-1374-1"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.313608"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.08.040"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2021.05.034"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.08.027"},{"issue":"1","key":"e_1_2_9_32_1","article-title":"Statins for the primary prevention of cardiovascular disease","volume":"2013","author":"Taylor F","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.10.050"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.09.017"},{"key":"e_1_2_9_35_1","unstructured":"US Food and Drug Administration.FDA drug safety communication: important safety label changes to cholesterol\u2010lowering statin drugs.2012. Available from:http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm293101.htmAccessed on February 28 2012."},{"key":"e_1_2_9_36_1","unstructured":"RosesonRS BakerSK.Statin muscle\u2010related adverse events. In:UpToDate post TW UpToDate Waltham MA. Accessed on March 30 2023."},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n135"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170379"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.4467"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v103.5087"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2021.03.024"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2021.07.190"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.19191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T08:06:06Z","timestamp":1692950766000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.19191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1111\/jdv.19191"],"URL":"https:\/\/doi.org\/10.1111\/jdv.19191","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"2023-02-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}